FTNT three-lens brief
Evidence-based stock research on FTNT. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 26.6pp over 30 days. · Trading at 95% of its 52-week range — near the top of the band.
- Trading at 95% of its 52-week range — near the top of the band.
- RSI at 82 — technically overbought.
- Outperforming SPY by 26.6pp over 30 days.
- Debt-to-equity of 85.8 — balance-sheet-heavy.
FTNT closed at $114.36 (+0.43%) as of 2026-05-13. Market cap: $83.79B. P/E (trailing) 44.3. Positives: outperforming SPY by 26.6pp over 30 days.. Concerns: trading at 95% of its 52-week range — near the top of the band.; rSI at 82 — technically overbought.. Last quarter: Revenue $1.91B, net income $506.00M, free cash flow $1.75B.
Why three lenses on FTNT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine FTNTacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/FTNT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath FTNT brief"></iframe>